Drug Profile
Research programme: intravenous GAD - Mertiva
Alternative Names: GAD 67; GAD65 intravenous - Diamyd Medical; rhGAD65 intravenous - Diamyd MedicalLatest Information Update: 30 Apr 2013
Price :
$50
*
At a glance
- Originator Mertiva
- Class
- Mechanism of Action Enzyme modulators; GABA modulators; Glutamate decarboxylase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy; Movement disorders; Stiff-person syndrome
Most Recent Events
- 30 Apr 2013 No development reported - Preclinical for Epilepsy in USA (IV)
- 30 Apr 2013 No development reported - Preclinical for Movement disorders in USA (IV)
- 30 Apr 2013 No development reported - Preclinical for Stiff-person syndrome in USA (IV)